Sharemaestro company-news research for CLARIVATE PLC (CLVT), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.

NYSE United States Provisional evidence

Company news sentiment

Latest CLVT news and sentiment

CLARIVATE PLC

Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.

30-day score51Neutral is 50
Early balanced news score 17/100 evidence confidence 99% direct company focus 12 current stories across 4 publishers
Latest weekly closeUSD 2.07week of 4 Sep 2026
Main news subjectEarnings80/100 share of current news
News data statusHealthy23 duplicate stories removed

Current company news

Early balanced news score

12 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.

Observed headline tone70/100 Published 30-day score51/100

Older, less relevant and less reliable stories count for less. Confidence is shown separately.

Latest source headline Clarivate Plc Share Price Live Today โ€“ NYSE:CLVT Stock Price, Chart, News, History Upstox ยท 04 Sep 2026 07:00

What supports the score

Direct evidence

12 current stories are mapped specifically to CLVT.

Source breadth

The score uses 4 publishers rather than depending on one outlet.

What limits the score

Too little evidence

The stories agree, but freshness-weighted evidence is only 0.061.

Confidence

Confidence is 17/100, below the threshold for a firm score.

51/100
News scoreEarly balanced news score
17/100
Confidencethin evidence
99%/100
Company news12 company stories
88/100
Story agreement12/100 difference

News history

Daily score and story count over 30 days

Daily weighted evidence
13 Aug: 3 stories14 Aug: 2 stories19 Aug: 2 stories24 Aug: 1 stories28 Aug: 1 stories04 Sep: 1 stories 13 Aug: tone 58, 3 stories14 Aug: tone 38, 2 stories19 Aug: tone 74, 2 stories24 Aug: tone 75, 1 stories28 Aug: tone 50, 1 stories04 Sep: tone 50, 1 stories 95505
13 Aug28 Aug11 Sep
News scoreStory count50 baseline

Confidence

How reliable the score is

Separate from direction

Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.

Amount of evidence1
0.061 after freshness weighting
Source breadth80
4 independent publishers
Company relevance99
share tied directly to this company
Freshness5
recency-weighted evidence
Agreement88
how closely stories agree
Publisher mix59
less reliance on one publisher

Price and news history

Weekly price and news-score history

Early company-news score

Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.

26 completed price weeks11 comparable news-score weeks
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
13 Mar 2026: close 2.57, indexed 100.020 Mar 2026: close 2.49, indexed 96.927 Mar 2026: close 2.36, indexed 91.803 Apr 2026: close 2.53, indexed 98.410 Apr 2026: close 2.17, indexed 84.417 Apr 2026: close 2.68, indexed 104.324 Apr 2026: close 2.45, indexed 95.301 May 2026: close 2.79, indexed 108.608 May 2026: close 2.78, indexed 108.215 May 2026: close 2.42, indexed 94.222 May 2026: close 2.45, indexed 95.329 May 2026: close 2.53, indexed 98.405 Jun 2026: close 2.41, indexed 93.812 Jun 2026: close 2.21, indexed 86.019 Jun 2026: close 2.04, indexed 79.426 Jun 2026: close 2.13, indexed 82.903 Jul 2026: close 2.59, indexed 100.810 Jul 2026: close 2.23, indexed 86.817 Jul 2026: close 2.39, indexed 93.024 Jul 2026: close 2.04, indexed 79.431 Jul 2026: close 1.98, indexed 77.007 Aug 2026: close 1.82, indexed 70.814 Aug 2026: close 1.93, indexed 75.121 Aug 2026: close 2.08, indexed 80.928 Aug 2026: close 2.02, indexed 78.604 Sep 2026: close 2.07, indexed 80.5 26 Jun 2026: news score 50, close 2.13, 5 stories5003 Jul 2026: news score 50, close 2.59, 9 stories10 Jul 2026: news score 51, close 2.23, 13 stories5117 Jul 2026: news score 49, close 2.39, 22 stories24 Jul 2026: news score 48, close 2.04, 34 stories4831 Jul 2026: news score 48, close 1.98, 56 stories07 Aug 2026: news score 50, close 1.82, 67 stories5014 Aug 2026: news score 51, close 1.93, 76 stories21 Aug 2026: news score 55, close 2.08, 66 stories5528 Aug 2026: news score 54, close 2.02, 34 stories04 Sep 2026: news score 52, close 2.07, 24 stories52 Price index 113.1 89.7 66.3 News score 100 50 0
13 Mar09 Jun04 Sep
Weekly close, indexedSentiment score
26-week price-19.5%latest close 2.07
News score change+2first to latest comparable week
One-week response+2.5%Price confirming higher
Fair-value position-57.9%Below fair value
WeekNews scoreCloseWeekly move
04 Sep 202652USD 2.07+2.5%
28 Aug 202654USD 2.02-2.9%
21 Aug 202655USD 2.08+7.8%
14 Aug 202651USD 1.93+6.0%
07 Aug 202650USD 1.82-8.1%
31 Jul 202648USD 1.98-2.9%
24 Jul 202648USD 2.04-14.6%
17 Jul 202649USD 2.39+7.2%
Provisional evidence

News subjects

What is shaping the score

Earnings
Earnings697 stories ยท 58%
Market update503 stories ยท 25%
Deals and strategy611 stories ยท 8%
Analyst action501 stories ยท 8%

Source mix

Where the evidence comes from

59/100 independence
vinanet.vn792 stories ยท 17%
Upstox502 stories ยท 17%
TradingKey381 stories ยท 8%
www.marketscreener.com611 stories ยท 8%
The Globe and Mail601 stories ยท 8%
TradingView501 stories ยท 8%
Simply Wall Street501 stories ยท 8%

Recurring subjects

Subjects appearing most often

Current evidence
Financial Markets7Earnings5Technology3Life Sciences3Finance2Restructuring1Mergers And Acquisitions1Insider Buying1Information Services1

Earlier readings

How the score has changed

43 comparable readings ยท 81 days
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
Comparable move+150 to 51 ยท Broadly stable
Observed range48โ€“5750 is the neutral baseline
Evidence depth12stories at latest stored reading ยท +11
Confidence16/100Provisional ยท +16
20 Jun50 neutral10 Sep 07:19
ConstructiveBalanced or withheldCautious

Changes in the stored score

Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.

ObservedScoreMoveConfidenceStoriesStatus
10 Sep 07:1951-116/100 (-2)12 (-12)Provisional
04 Sep 23:5952-218/100 (-7)24 (-10)Provisional
28 Aug 23:5954-325/100 (-6)34 (-24)Provisional
24 Aug 23:5957+131/100 (-4)58 (-8)Provisional
19 Aug 23:5956+535/100 (+4)66 (-10)Provisional
14 Aug 23:5951+031/100 (0)76 (+1)Provisional
13 Aug 23:5951+031/100 (-3)75 (+3)Provisional
11 Aug 23:5951+034/100 (-3)72 (+1)Measured

Source headlines

The news behind the score

Showing 1-12 of 12

Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.

#1Not directional
UpstoxDirect company coverageScored from headline

Clarivate Plc Share Price Live Today โ€“ NYSE:CLVT Stock Price, Chart, News, History

Published
04 Sep 2026 07:00
News subject
Market update
Why this score
The headline reports news without a clear direction
Company focus
Main company ยท 100%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 6.0d old
Duplicates
1 consolidated
#2Not directional
UpstoxDirect company coverageScored from headline

Clarivate Plc Share Price Live Today โ€“ NYSE:CLVT Stock Price, Chart, News, History

Published
28 Aug 2026 07:00
News subject
Market update
Why this score
The headline reports news without a clear direction
Company focus
Main company ยท 100%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 13.0d old
Duplicates
1 consolidated
#375Tone
vinanet.vnDirect company coverageScored from headline

Clarivate (CLVT) Results Versus Estimates: EPS Lands Above Forecast at the Close; Trading Response: Shares Close 3.12% Higher in the Latest Session - Downward Estimate Revision

Published
24 Aug 2026 15:47
News subject
Earnings
Why this score
Beat expectations
Company focus
Main company ยท 100%
How it is used
Direct company coverage
Story strength
Medium ยท 56/100
30-day weight
35.1% of the score ยท 16.6d old
Duplicates
1 consolidated
#460Tone
The Globe and MailDirect company coverageStored article

Clarivate Director Cornick Buys 900,000 Shares for $1.7 Million. What Does This Tell Investors About the Outlook for 2026?

Clarivate Plc Director Kenneth L. Cornick purchased 900,000 shares of the company's stock for $1.7 million, increasing his total holdings by 74% to approximately 2.1 million shares. This significant insider buying, executed through Cornick Family Investor, LLC, signals a bullish outlook despite the stock's 52% decline over the past year and analysts' projections of declining sales. Management believes recent restructuring and the sale of non-core divisions will lead to more predictable revenue and long-term growth.

EarningsFinanceFinancial MarketsInformation ServicesInsider BuyingRestructuring
Published
19 Aug 2026 15:42
News subject
Earnings
Why this score
Institutional or insider buying
Company focus
Main company ยท 100%
How it is used
Direct company coverage
Story strength
Medium ยท 39/100
30-day weight
16.1% of the score ยท 21.7d old
Duplicates
4 consolidated
#584Tone
vinanet.vnDirect company coverageScored from headline

Clarivate (CLVT) Results Versus Estimates: EPS Prints Above Forecast on the Day; Market Move: The Immediate Price Response Is Limited in Latest Trading - Margin Expansion Trends

Published
19 Aug 2026 09:45
News subject
Earnings
Why this score
Beat expectations, Margin Expansion
Company focus
Main company ยท 100%
How it is used
Direct company coverage
Story strength
High ยท 64/100
30-day weight
23.6% of the score ยท 21.9d old
Duplicates
1 consolidated
#638Tone
TradingKeyDirect company coverageStored article

CLVT|Clarivate PLC|Price:1.923|Chg%:-0.037

This article provides a detailed overview of Clarivate PLC (CLVT) stock, including its current price, market capitalization, key financial figures, and recent performance. It also covers analyst ratings, a technical analysis summary, company profile, and major shareholders. The stock's current rating is "Hold" with a target price indicating a significant upside potential.

EarningsFinanceFinancial MarketsLife SciencesTechnology
Published
14 Aug 2026 20:12
News subject
Earnings
Why this score
Negative market reaction
Company focus
Shared story ยท 78%
How it is used
Direct company coverage
Story strength
Low ยท 35/100
30-day weight
6.3% of the score ยท 26.5d old
Duplicates
1 consolidated
#7Not directional
TradingViewDirect company coverageStored article

ETFs Investing in Clarivate PLC Stocks

This article lists various Exchange Traded Funds (ETFs) that hold Clarivate PLC (16A) stocks, providing investors with options to invest in the company indirectly. Each ETF entry includes details such as market value, weight of Clarivate PLC in the fund, issuer, management style, focus, expense ratio, assets under management (AUM), price, and 3-year NAV total return. The ETFs predominantly focus on small-cap, value, and extended market strategies.

Financial Markets
Published
14 Aug 2026 07:42
News subject
Market update
Why this score
The headline reports news without a clear direction
Company focus
Shared story ยท 78%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 27.0d old
Duplicates
1 consolidated
#8Not directional
Simply Wall StreetDirect company coverageStored article

Does Clarivateโ€™s Expanded Agentic AI Across Cortellis Reshape the Bull Case For Clarivate (CLVT)?

Clarivate Plc has expanded agentic AI capabilities across its Cortellis life sciences portfolio, aiming to integrate AI into drug discovery, safety assessment, and portfolio decision workflows. This move seeks to reduce manual effort and support faster, evidence-based decisions, reinforcing Clarivate's investment narrative around workflow integration and efficiency. While this could enhance the bull case, investors should remain aware of potential risks such as competition, pricing pressure, continued net losses, and the company's high debt load.

EarningsFinancial MarketsLife SciencesTechnology
Published
13 Aug 2026 17:11
News subject
Earnings
Why this score
Positive analyst conviction
Company focus
Shared story ยท 78%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 27.6d old
Duplicates
2 consolidated
#9Not directional
SahmDirect company coverageStored article

Is Clarivate (CLVT) Below Fair Value On Its Cortellis Agentic AI Expansion?

Clarivate (CLVT) has expanded its Cortellis portfolio with new agentic AI capabilities aimed at accelerating life sciences R&D, despite its stock experiencing a significant decline. The company's valuation narrative suggests it is undervalued at $2.50 per share compared to its current price of $1.91, emphasizing recurring revenue and future profit potential. However, concerns about higher education budgets and competition from free research data could impact its growth.

EarningsFinancial MarketsLife SciencesTechnology
Published
13 Aug 2026 06:42
News subject
Earnings
Why this score
Positive valuation view
Company focus
Main company ยท 100%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 28.0d old
Duplicates
1 consolidated
#1061Tone
www.marketscreener.comDirect company coverageStored article

Clarivate : and KYBORA Partner to Help Biopharma Companies Execute Strategic Transaction Outcomes

Clarivate and KYBORA have partnered to offer integrated, end-to-end transaction advisory services for bioph

Mergers And Acquisitions
Published
13 Aug 2026 06:41
News subject
Deals and strategy
Why this score
Strategic partnership
Company focus
Main company ยท 100%
How it is used
Direct company coverage
Story strength
Medium ยท 41/100
30-day weight
19% of the score ยท 28.0d old
Duplicates
1 consolidated
#11Not directional
MarketBeatDirect company coverageStored article

Clarivate (NYSE:CLVT) Shares Gap Up on Insider Buying Activity

Clarivate (NYSE:CLVT) shares gapped up after Director Kenneth L. Cornick purchased 900,000 shares across two transactions totaling approximately $1.67 million. This insider buying activity occurred despite cautious analyst sentiment, with a consensus "Reduce" rating and a price target of $3.02. The company slightly exceeded EPS estimates but reported a 5.5% year-over-year revenue decline.

EarningsFinancial Markets
Published
11 Aug 2026 14:18
News subject
Earnings
Why this score
Beat expectations, Analyst downgrade, Operating deterioration, Institutional or insider buying
Company focus
Main company ยท 100%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 29.7d old
Duplicates
1 consolidated
#12Not directional
Yahoo! Finance CanadaDirect company coverageStored article

Clarivate PLC (16A.MU) Analyst Insights, Price Targets & Recommendations

This article provides analyst ratings and price targets for Clarivate PLC (16A.MU). It lists recent "Upgrades & Downgrades" showing various firms maintaining their ratings, including Citigroup, Goldman Sachs, Stifel, and Barclays, with the latest update on July 30, 2026. The stock's current price is 1.6740 EUR.

Financial Markets
Published
11 Aug 2026 13:18
News subject
Analyst action
Why this score
The headline reports news without a clear direction
Company focus
Main company ยท 100%
How it is used
Shown as company news ยท not used in the score
Story strength
Not directional
30-day weight
None ยท 29.8d old
Duplicates
1 consolidated

Earlier company news

CLVT news archive

Showing 1-30 of 87 stored headlines

Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.

Aug 10 2026
MarketBeatArchivedPositive tone

Kenneth Cornick Acquires 650,000 Shares of Clarivate (NYSE:CLVT) Stock

Clarivate director Kenneth Cornick recently acquired 650,000 shares of NYSE:CLVT stock for approximately $1.21 million, significantly increasing his direct ownership by 59.09% to 1.75 million shares. Despite Clarivate's shares rising 4.4% to $1.90, they remain near their one-year low, and analysts maintain a cautious "Reduce" rating with a $3.02 target price. The company reported a Q2 EPS of $0.19, beating estimates, though revenue declined by 5.5% year-over-year.

EarningsFinanceFinancial MarketsLife Sciences
Published
10 Aug 2026 22:14
Catalyst
Analyst action
Coverage
Direct company
Duplicates
1 consolidated
Aug 10 2026
MarketBeatArchivedPositive tone

Clarivate (NYSE:CLVT) Director Kenneth Cornick Buys 250,000 Shares of Stock

Clarivate (NYSE:CLVT) Director Kenneth Cornick purchased 250,000 shares of the company's stock on August 7th, investing $462,500 at an average price of $1.85 per share. This transaction increased his direct ownership to 2 million shares, a 14.29% increase. Despite the insider buying, analyst sentiment remains cautious, with a consensus "Reduce" rating and a target price of $3.02, following a recent earnings report that showed a 5.5% year-over-year revenue decline.

EarningsFinanceFinancial MarketsLife Sciences
Published
10 Aug 2026 22:14
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Aug 10 2026
MarketBeatArchivedPositive tone

Kenneth Cornick Acquires 650,000 Shares of Clarivate (NYSE:CLVT) Stock

Clarivate director Kenneth Cornick recently acquired 650,000 shares of NYSE:CLVT stock for approximately $1.21 million, significantly increasing his direct ownership by 59.09% to 1.75 million shares. Despite Clarivate's shares rising 4.4% to $1.90, they remain near their one-year low, and analysts maintain a cautious "Reduce" rating with a $3.02 target price. The company reported a Q2 EPS of $0.19, beating estimates, though revenue declined by 5.5% year-over-year.

EarningsFinanceFinancial MarketsLife Sciences
Published
10 Aug 2026 08:00
Catalyst
Analyst action
Coverage
Direct company
Duplicates
1 consolidated
Aug 10 2026
MarketBeatArchivedPositive tone

Clarivate (NYSE:CLVT) Director Kenneth Cornick Buys 250,000 Shares of Stock

Clarivate (NYSE:CLVT) Director Kenneth Cornick purchased 250,000 shares of the company's stock on August 7th, investing $462,500 at an average price of $1.85 per share. This transaction increased his direct ownership to 2 million shares, a 14.29% increase. Despite the insider buying, analyst sentiment remains cautious, with a consensus "Reduce" rating and a target price of $3.02, following a recent earnings report that showed a 5.5% year-over-year revenue decline.

EarningsFinanceFinancial MarketsLife Sciences
Published
10 Aug 2026 08:00
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Aug 09 2026
TradingViewArchivedNeutral tone

Enterprise value to EBIT forward of Clarivate Plc โ€“ NYSE:CLVT

The article focuses on the enterprise value to EBIT forward for Clarivate Plc (NYSE: CLVT). It presents financial data within the TradingView platform context, highlighting the company's stock information and financial metrics. The primary content available is a data point for this specific financial ratio.

FinanceFinancial Markets
Published
9 Aug 2026 10:10
Catalyst
Market update
Coverage
Direct company
Duplicates
1 consolidated
Aug 07 2026
Simply Wall St.ArchivedNeutral tone

Can Clarivateโ€™s (CLVT) Agentic AI Push Deepen Its Moat Or Signal A Riskier Shift?

Clarivate Plc recently expanded agentic AI capabilities across its Cortellis portfolio, embedding natural language and multiโ€‘agent tools into life sciences R&D, safety and competitive intelligence workflows to cut manual effort and speed evidence-based decisions. This move effectively turns Cortellis into a more embedded decision engine for pharma and biotech customers, potentially deepening workflow integration and data dependence across the drug development lifecycle. We'll now consider how Clarivate's push into agentic AI within Cortellis may influence its investment narrative and longer-te

AIBiotechEarningsPharma
Published
7 Aug 2026 18:18
Catalyst
Earnings
Coverage
Direct company
Duplicates
2 consolidated
Aug 07 2026
ClarivateArchivedNeutral tone

Knowledge graphs: Turning fragmented biomedical data into connected, actionable insight

This article discusses how knowledge graphs address the challenge of fragmented biomedical data, transforming it into actionable insights. It highlights that the problem is not data abundance but usability, with knowledge graphs connecting disparate data points into a unified framework. The piece also explains how Clarivate's AI-powered knowledge graphs are built with trusted data to drive impact across the R&D continuum and make complex information accessible through AI agents.

Life Sciences
Published
7 Aug 2026 09:40
Catalyst
Market update
Coverage
Direct company
Duplicates
1 consolidated
Aug 07 2026
finance.yahoo.comArchivedPositive tone

Owens Corning (OC) Is Up 8.5% After Q2 Earnings Beat, Buybacks And CFO Transition โ€“ What's Changed

In early August 2026, Owens Corning reported second-quarter 2026 results showing broadly flat sales at US$2,756 million year on year, but a decline in net income to US$226 million and lower earnings per share compared with the prior-year quarter. Alongside these results, the company completed two substantial share repurchase programs totaling about 11.79% and 1.53% of its shares since late 2022 and mid-2025, while also announcing a CFO transition that elevates former finance chief Todd Fister to President and COO and brings in experienced finance leader Jonathan Collins from Clarivate. We'll n

ConstructionEarningsEarnings Per ShareEarnings SurpriseHousingNet Income
Published
7 Aug 2026 09:15
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Aug 07 2026
Yahoo! Finance CanadaArchivedNeutral tone

Clarivate Plc (CLVT) Stock Forecasts

Clarivate Plc (CLVT) is a data, information, and software workflow solutions company, primarily serving academia, government, law, life sciences, and healthcare sectors. An analyst report from Morningstar on August 6, 2026, suggests that Clarivate is in the early stages of a multiyear turnaround. The company, formerly part of Thomson Reuters, was sold to private equity before becoming independent.

Financial MarketsLife SciencesTechnology
Published
7 Aug 2026 06:40
Catalyst
Analyst action
Coverage
Direct company
Duplicates
1 consolidated
Aug 06 2026
MT NewswiresArchivedNegative tone

Clarivate Insider Sold Shares Worth $4,829,859, According to a Recent SEC Filing

An insider at Clarivate Plc reportedly sold shares valued at $4,829,859, as per a recent SEC filing. The article, published by MT Newswires, provides this financial transaction detail but restricts the full content to members. Clarivate Plc is a provider of transformative intelligence solutions across Academia & Government, Intellectual Property, and Life Sciences & Healthcare segments.

EarningsFinanceFinancial MarketsLife Sciences
Published
6 Aug 2026 09:37
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Aug 06 2026
www.marketscreener.comArchivedNegative tone

Clarivate Insider Sold Shares Worth $4,829,859, According to a Recent SEC Filing

An insider at Clarivate Plc reportedly sold shares valued at $4,829,859, as per a recent SEC filing. The article, published by MT Newswires, provides this financial transaction detail but restricts the full content to members. Clarivate Plc is a provider of transformative intelligence solutions across Academia & Government, Intellectual Property, and Life Sciences & Healthcare segments.

EarningsFinanceFinancial MarketsLife Sciences
Published
6 Aug 2026 09:11
Catalyst
Earnings
Coverage
Direct company
Duplicates
2 consolidated
Aug 06 2026
PR NewswireArchivedNeutral tone

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

Expanded capabilities across Cortellis portfolio help life sciences organizations turn trusted intelligence into action and accelerate decision making across the research and development lifecycle LONDON, Aug. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the expansion of agentic AI capabilities across the Cortellis portfolio, helping life sciences R&D teams accelerate discovery, strengthen safety assessment and make faster, more informed portfolio decisions. By embedding AI directly within existing workflows, the n

AIDrug DevelopmentDrug DiscoveryLife SciencesPortfolio StrategySafety Assessment
Published
6 Aug 2026 09:00
Catalyst
Market update
Coverage
Direct company
Duplicates
3 consolidated
Aug 06 2026
MarketBeatArchivedNegative tone

Andrew Miles Snyder Sells 2,489,618 Shares of Clarivate (NYSE:CLVT) Stock

Clarivate director Andrew Miles Snyder sold 2,489,618 shares of CLVT stock at an average price of $1.94, totaling approximately $4.83 million, reducing his direct ownership by 39.23%. This transaction occurred as Clarivate shares traded near their 52-week low and the company reported quarterly EPS of $0.19, slightly above expectations, despite a 5.5% year-over-year revenue decline. Analyst sentiment for Clarivate remains cautious, with a consensus "Reduce" rating, even though institutional investors hold a significant 85.72% of the stock.

EarningsFinanceFinancial Markets
Published
6 Aug 2026 04:41
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Aug 05 2026
MarketBeatArchivedPositive tone

Arrowstreet Capital Limited Partnership Acquires Shares of 1,320,982 Clarivate PLC $CLVT

Arrowstreet Capital Limited Partnership recently acquired 1,320,982 shares of Clarivate PLC (NYSE:CLVT) worth approximately $3.34 million, marking a new position and a 0.21% stake in the company. Despite Clarivate beating analyst EPS estimates with $0.19, its revenue of $587.3 million fell short of expectations and declined year-over-year. Institutional ownership stands at 85.72%, while analyst sentiment remains cautious, with a consensus "Reduce" rating and an average price target of $3.02, significantly higher than its recent trading price of $1.97.

EarningsFinanceFinancial MarketsLife Sciences
Published
5 Aug 2026 09:15
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Aug 05 2026
MarketBeatArchivedNegative tone

Andrew Miles Snyder Sells 2,489,618 Shares of Clarivate (NYSE:CLVT) Stock

Clarivate director Andrew Miles Snyder sold 2,489,618 shares of CLVT stock at an average price of $1.94, totaling approximately $4.83 million, reducing his direct ownership by 39.23%. This transaction occurred as Clarivate shares traded near their 52-week low and the company reported quarterly EPS of $0.19, slightly above expectations, despite a 5.5% year-over-year revenue decline. Analyst sentiment for Clarivate remains cautious, with a consensus "Reduce" rating, even though institutional investors hold a significant 85.72% of the stock.

EarningsFinanceFinancial Markets
Published
5 Aug 2026 08:00
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Aug 04 2026
TradingViewArchivedNegative tone

Weekly Recap: Clarivate PLC Q2 2026 results and Michael Easton named CFO

Clarivate PLC (NYSE:CLVT) reported Q2 2026 results including $587.3M revenue, a GAAP loss of $268.6M, but adjusted net income of $123.1M and adjusted EBITDA of $247.2M. Michael Easton will become the new CFO on August 8, 2026, replacing Jonathan Collins. Following the results, Stifel lowered its price target for CLVT from $6.00 to $5.00.

EarningsFinancial Markets
Published
4 Aug 2026 02:09
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Aug 04 2026
Investing.com NigeriaArchivedNeutral tone

Form 144 Clarivate Plc For: 3 August By Investing.com

This article from Investing.com reports the filing of Form 144 for Clarivate Plc on August 3rd. It briefly mentions Clarivate's stock symbol CLVT and its stock performance (+1.55%). The article also includes various market data like indices, commodities, and share prices, though these appear to be general market data rather than directly related to Clarivate's Form 144.

Financial Markets
Published
4 Aug 2026 01:46
Catalyst
Market update
Coverage
Direct company
Duplicates
1 consolidated
Aug 04 2026
Stock TitanArchivedNeutral tone

Clarivate (CLVT) plans potential NYSE sale of ProQuest merger consideration shares

Clarivate plc has filed a Form 144 notice indicating a potential sale of 2,489,618 ordinary shares on the NYSE through J.P. Morgan Securities LLC. These shares were originally acquired on December 1, 2021, as consideration for the merger of ProQuest LLC into Clarivate. The filing signals that these previously issued shares may now be sold on the open market.

FinanceFinancial MarketsMergers And Acquisitions
Published
4 Aug 2026 01:11
Catalyst
Deals and strategy
Coverage
Direct company
Duplicates
1 consolidated
Aug 01 2026
MarketBeatArchivedNegative tone

Clarivate (NYSE:CLVT) Lowered to Hold Rating by Wall Street Zen

Wall Street Zen has downgraded Clarivate (NYSE:CLVT) from a "Buy" to a "Hold" rating. This move contributes to an overall bearish sentiment among analysts, with the stock currently holding a consensus "Reduce" rating and an average price target of $3.02. Clarivate's shares opened at $2.00, below key moving averages, and the company reported narrowly beating earnings expectations but missing revenue estimates with a 5.5% year-over-year decline.

EarningsFinanceFinancial MarketsLife SciencesTechnology
Published
1 Aug 2026 06:10
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Jul 30 2026
MarketBeatArchivedNegative tone

Clarivate (NYSE:CLVT) Price Target Lowered to $5.00 at Stifel Nicolaus

Stifel Nicolaus has lowered its price target for Clarivate (NYSE:CLVT) from $6.00 to $5.00, while maintaining a "buy" rating, indicating a potential 149% upside from its current share price of $2.00. Despite beating EPS estimates, the company's Q2 revenue of $587.3 million missed expectations and declined 5.5% year-over-year, alongside a negative net margin. Clarivate's stock fell 6.7% to $2.00, and the broader analyst consensus currently rates it as "Reduce" with an average target of $3.23.

EarningsFinanceFinancial MarketsLife Sciences
Published
30 Jul 2026 18:39
Catalyst
Analyst action
Coverage
Direct company
Duplicates
1 consolidated
Jul 30 2026
MarketBeatArchivedNegative tone

Clarivate PLC (NYSE:CLVT) Given Average Rating of "Reduce" by Brokerages

Clarivate PLC (NYSE:CLVT) has received a consensus "Reduce" rating from seven brokerages, with an average 12-month price target of $2.88. Despite slightly beating adjusted EPS estimates, the company's revenue declined 5.5% year-over-year and fell short of expectations, indicating ongoing profitability challenges. Several institutional investors have adjusted their holdings in Clarivate, and positive news includes reaffirming its 2026 financial outlook and strategic initiatives related to AI and divestitures, juxtaposed with negative sentiment around its revenue miss.

EarningsFinancial MarketsLife SciencesTechnology
Published
30 Jul 2026 13:39
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Jul 29 2026
finance.yahoo.comArchivedNeutral tone

Clarivate PLC (CLVT) Q2 2026 Earnings Call Highlights: Strategic Shifts and AI Innovations ...

This article first appeared on GuruFocus. Release Date: July 29, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Clarivate PLC (NYSE:CLVT) reported an improvement in organic Annual Contract Value (ACV) growth to 1.5% and expanded profit margins to over 42%. The company introduced two new AI products, Nexus Connect and IP1, which are expected to drive new revenue streams. Clarivate PLC (NYSE:CLVT) announced the sale of its Life Science and Health segment, which will sharpen its focus on AI-driven intelligence and improve

AIBalance SheetDebt ReductionDivestitureEarningsFree Cash Flow
Published
29 Jul 2026 22:05
Catalyst
Earnings
Coverage
Direct company
Duplicates
3 consolidated
Jul 29 2026
Stock TitanArchivedNeutral tone

Clarivate (NYSE: CLVT) promotes Michael Easton to CFO role

Clarivate Plc announced the promotion of Michael Easton to Executive Vice President & Chief Financial Officer, effective August 8, 2026, following Jonathan Collins' resignation. Easton, previously Senior Vice President, Finance & Chief Accounting Officer, will receive a $600,000 base salary, 100% target annual bonus, and significant equity incentives. Concurrently, Matthew Lisowski was promoted to Senior Vice President, Chief Accounting Officer.

EarningsFinance
Published
29 Jul 2026 21:41
Catalyst
Earnings
Coverage
Direct company
Duplicates
1 consolidated
Jul 29 2026
ClarivateArchivedNeutral tone

RiskMark wins Best AI Tool For Lawyers at the 2026 CODiE awards

RiskMark, an AI-powered trademark risk assessment solution by Clarivate, has won the Best AI Tool for Lawyers at the 2026 CODiE Awards, following its 2025 LegalTech Breakthrough Award. The platform helps legal professionals assess the likelihood of confusion, identify potential trademark conflicts, and develop stronger legal arguments using proprietary trademark data and legal precedent intelligence. RiskMark integrates predictive and generative AI, significantly reducing manual review time for trademark professionals.

Technology
Published
29 Jul 2026 15:40
Catalyst
Market update
Coverage
Direct company
Duplicates
1 consolidated
Jul 29 2026
Investing.comArchivedNegative tone

Earnings call transcript: Clarivate posts mixed Q2 2026 results as shares fall

Clarivate Plc Q2 2026 Earnings Call Summary - Moby Strategic Execution and Portfolio Optimization Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Management is executing a Value Creation Plan (VCP) focused on shifting the business model from transactional to high-quality recurring subscription revenue. The divestiture of the Life Sciences & Healthcare (LS&H) segment is a key strategic pivot to simplify the operating model and concentrate capital on the Academia & Government (A&G) and Intell

AIBalance SheetDebt ReductionDivestitureEarningsRestructuring
Published
29 Jul 2026 15:24
Catalyst
Earnings
Coverage
Direct company
Duplicates
2 consolidated
Jul 29 2026
finance.yahoo.comArchivedNeutral tone

Clarivate (CLVT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Clarivate PLC (CLVT) reported $587.3 million in revenue for the quarter ended June 2026, representing a year-over-year decline of 5.5%. EPS of $0.19 for the same period compares to $0.18 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $587.06 million, representing a surprise of +0.04%. The company delivered an EPS surprise of +11.77%, with the consensus EPS estimate being $0.17. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action

Earnings
Published
29 Jul 2026 14:30
Catalyst
Earnings
Coverage
Direct company
Duplicates
2 consolidated

Provider matches checked

Provider mentions not used in the score

6 not scored

A news provider linked these stories to CLVT, but the headline and available text are not mainly about CLARIVATE PLC. They are kept here for transparency and do not affect the score, confidence, history or wider market totals.

Provider mentions are kept separate

Open the list to see which provider matches were checked and left out of CLVT sentiment.

Open provider mentions

How the page works

How to read the score

The score shows direction

It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.

Confidence is separate

Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.

Price is confirmation

Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.

What the page does

It measures news already published. It is not a forecast, recommendation or price target.

Evidence context